Contract analysis

1. Meridian Consumer Brands LLC Meridian Consumer Brands LLC is a Delaware limited liability company registered to do business in the State of New York, with its principal place of business at 410 West 34th Street, 18th Floor, New York, New York 10001. Whitmore Decl. ¶ 1. Meridian develops, markets, and distributes premium skincare, personal-care, and over-the-counter ("OTC") dermatological products sold through reta

2. Apex Naturals Inc. Defendant Apex Naturals Inc. is a Delaware corporation with its principal place of business at 75 Commerce Boulevard, Suite 300, Parsippany, New Jersey 07054. Whitmore Decl. ¶ 9. Apex develops and sells mass-market and "clean-beauty" skincare and acne-treatment products distributed primarily through drugstore retail channels and e-commerce platforms throughout the United States. Id. Apex's princ

1. The Fabricated Clinical Superiority Claim The campaign prominently and repeatedly states: "In a controlled clinical study, PuraClear reduced visible acne blemishes 47% faster than the leading DermaTrūe treatment." Whitmore Decl. ¶ 16. This claim appears in the television spots, digital video advertisements, print advertisements, in-store point-of-sale displays, and on the campaign webpage. Id. In each instance, th

2. The Misleading Price Comparison Claim The campaign states: "PuraClear delivers premium results at half the price — just $12.99 vs. $28.99 for a comparable DermaTrūe kit." Whitmore Decl. ¶ 21. This claim appears in substantially the same form across the campaign's television, digital, print, and in-store materials, and on the campaign webpage. Id. This price comparison is materially misleading because it compares p

3. The False "Clean" Ingredients Claim The campaign states: "Unlike DermaTrūe, PuraClear is 100% free of parabens, sulfates, and synthetic fragrances." Whitmore Decl. ¶ 26. This claim appears prominently in television spots, digital advertisements, in-store point-of-sale materials, and on the campaign webpage. Id. This claim is literally false. In 2024, Meridian completed a comprehensive reformulation of its DermaTrū

I. MERIDIAN IS LIKELY TO SUCCEED ON THE MERITS OF ITS LANHAM ACT CLAIM A. Legal Framework for Lanham Act § 43(a) False Advertising

Section 43(a) of the Lanham Act, codified at 15 U.S.C. § 1125(a)(1)(B), creates a federal cause of action against any person who, "in commercial advertising or promotion, misrepresents the nature, characteristics, qualities, or geographic origin of his or her or another person's goods, services, or commercial activities." To prevail on a claim of false advertising under this provision, a plaintiff must establish five

II. MERIDIAN WILL SUFFER IRREPARABLE HARM ABSENT INJUNCTIVE RELIEF Meridian has demonstrated — and continues to suffer — irreparable harm that cannot be adequately compensated by money damages alone. The record evidence establishes irreparable harm through multiple, independent pathways: the ongoing erosion of DermaTrūe's brand goodwill and reputation; the presumption of irreparable harm arising from literal falsity